Closed Bioreactor for Pluripotent Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for differentiating pluripotent stem cells into specific cell types are labor-intensive, difficult to scale, and prone to contamination, with existing bioreactor systems facing challenges in maintaining sterility and efficiency in producing vast amounts of differentiated cells under Good Manufacturing Practice (GMP) conditions.
Innovation Solution
A closed culture system method involving a bioreactor setup with controlled pH and medium exchange, where pluripotent stem cells are cultivated in a single cell suspension to form aggregates, allowing for simultaneous proliferation and differentiation without the need for extensive medium replacement, reducing manual handling and centrifugation steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If manual procedures in small dishes or flasks are used for differentiating pluripotent stem cells, then cell differentiation can be achieved, but the process becomes labor-intensive and yields only a few million cells per dish, making large-scale manufacturing impossible
Solution Approach 1:
The patent replaces manual mechanical handling procedures with an automated bioreactor system that uses controlled fluid dynamics, pH regulation, and automated medium exchange to perform differentiation tasks, thereby eliminating labor-intensive operations while scaling up cell yield from millions per dish to billions per bioreactor run
Solution Approach 2:
The invention changes the physical and chemical parameters of the culture system by transitioning from static small dishes to dynamic bioreactors with controlled pH (maintained between 6.8-7.4), automated medium exchange rates, and controlled agitation, enabling large-scale production while maintaining differentiation efficiency
2Productivity
If bioreactor systems are used for large-scale cell production, then productivity increases, but maintaining sterility and preventing contamination becomes more difficult
Solution Approach 1:
The patent implements a closed bioreactor system that maintains an inert, controlled environment with regulated pH (6.8-7.4), temperature, and gas exchange, preventing contamination while enabling large-scale cell production without exposure to external contaminants
Solution Approach 2:
The invention uses automated medium exchange systems with sterile filters and controlled fluid pathways as intermediaries between the external environment and the cell culture, allowing nutrient supply and waste removal while maintaining sterility barriers that prevent contamination
3Reliability
If extensive medium replacement and centrifugation steps are used, then cell culture maintenance is achieved, but the process becomes more complex and time-consuming
Solution Approach 1:
The patent implements continuous automated medium exchange that maintains cell culture conditions without interruption, eliminating the need for discrete centrifugation and manual medium replacement steps, thereby simplifying the process while maintaining reliable cell culture maintenance
Solution Approach 2:
The bioreactor system performs self-monitoring and self-adjustment of pH, temperature, and medium exchange rates based on pre-programmed protocols, eliminating the need for complex manual intervention and reducing overall process complexity while maintaining culture reliability
4Ease of operation
If manual handling procedures are used, then cell manipulation is possible, but contamination risk increases significantly
Solution Approach 1:
The patent replaces all manual mechanical handling with automated robotic systems and controlled fluid delivery mechanisms that manipulate cells through sterile, closed pathways, maintaining full cell manipulation capability while eliminating the contamination risk associated with manual operations
Solution Approach 2:
The invention maintains cells throughout the entire process within a closed, sterile bioreactor environment that prevents exposure to external contaminants, eliminating contamination risk while automated systems provide full manipulation capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the efficient and scalable production of high yields of differentiated cells with improved reproducibility and reduced contamination risk, achieving high output-to-input ratios and maintaining cell quality, thus addressing the limitations of existing technologies.
Implementation Method 1
mixing the culture medium in the culture vessel thereby allowing the cells to grow in the form of cell aggregates and preventing settling of the cell aggregates
Implementation Method 2
discontinuing the mixing of the culture medium in the culture vessel thereby allowing the cell aggregates to settle
Data Source
AI summary
The present invention is in the field of pluripotent stem cells. In particular the invention relates to a method for (closed system) induction of differentiation of pluripotent stem cells towards a pre-selected cell type, such as, for example, cardiomyocytes or endothelial cells. The method as disclosed herein is particularly useful to upscale the production of cells derived from pluripotent stem cells, in particular (human) cardiomyocytes and/or endothelial cells derived from pluripotent stem cells.